
T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2025 Update
Description
Summary
T2 Biosystems Inc (T2 Biosystems) is an in vitro diagnostics company specializing in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The company's activities carry out developing technology that enables the rapid detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. Its products include the T2Dx Instrument, T2Bacteria Panel, T2Candida Panel, T2Resistance Panel, and T2Biothreat Panel. T2 Biosystems' products are used by healthcare providers to address critical healthcare conditions such as sepsis, bioterrorism, and Lyme disease. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
T2 Biosystems Inc (T2 Biosystems) is an in vitro diagnostics company specializing in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The company's activities carry out developing technology that enables the rapid detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types. Its products include the T2Dx Instrument, T2Bacteria Panel, T2Candida Panel, T2Resistance Panel, and T2Biothreat Panel. T2 Biosystems' products are used by healthcare providers to address critical healthcare conditions such as sepsis, bioterrorism, and Lyme disease. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company T2 Biosystems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
45 Pages
- T2 Biosystems Inc Company Overview
- T2 Biosystems Inc Company Snapshot
- T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
- T2 Biosystems Inc – Pipeline Analysis Overview
- T2 Biosystems Inc - Key Facts
- T2 Biosystems Inc - Major Products and Services
- T2 Biosystems Inc Pipeline Products by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc Pipeline Products Overview
- Comprehensive Sepsis Panel
- Comprehensive Sepsis Panel Product Overview
- Monkeypox Molecular Diagnostic Test Kit
- Monkeypox Molecular Diagnostic Test Kit Product Overview
- Next Generation T2Dx Instrument
- Next Generation T2Dx Instrument Product Overview
- T2Bacteria Panel - Pediatrics
- T2Bacteria Panel - Pediatrics Product Overview
- T2Candida Panel
- T2Candida Panel Product Overview
- T2Candida Panel Clinical Trial
- T2Carba Resistance
- T2Carba Resistance Product Overview
- T2Cauris Panel
- T2Cauris Panel Product Overview
- T2Dx - Cancer
- T2Dx - Cancer Product Overview
- T2Dx - Cardiac
- T2Dx - Cardiac Product Overview
- T2Dx Instrument
- T2Dx Instrument Product Overview
- T2Endotoxin
- T2Endotoxin Product Overview
- T2HemoStat
- T2HemoStat Product Overview
- T2Lyme Panel
- T2Lyme Panel Product Overview
- T2MR Assay - Platelet Function Testing
- T2MR Assay - Platelet Function Testing Product Overview
- T2Plex
- T2Plex Product Overview
- T2Resistance Panel
- T2Resistance Panel Product Overview
- T2Resistance Panel - Expansion
- T2Resistance Panel - Expansion Product Overview
- T2 Biosystems Inc - Key Competitors
- T2 Biosystems Inc - Key Employees
- T2 Biosystems Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- T2 Biosystems Inc, Recent Developments
- Dec 18, 2024: T2 Biosystems Announces Sale of Four T2Dx Instruments to Existing European Distributor
- Dec 17, 2024: T2 Biosystems Achieves Key Milestone with 250,000th Novel Sepsis Test Shipped Globally
- Dec 09, 2024: T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
- Oct 08, 2024: T2 Biosystems to Host Business Update Call on October 10, 2024
- Oct 07, 2024: T2 Biosystems Announces Exclusive U.S. Agreement with Cardinal Health to Sell Its FDA-Cleared Direct-From-Blood Diagnostics for Rapid Detection of Sepsis-Causing Pathogens
- May 06, 2024: T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
- May 06, 2024: T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
- Mar 28, 2024: T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient
- Mar 20, 2024: T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
- Oct 24, 2023: T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
- T2 Biosystems Inc Pipeline Products by Equipment Type
- T2 Biosystems Inc Pipeline Products by Indication
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc, Key Facts
- T2 Biosystems Inc, Major Products and Services
- T2 Biosystems Inc Number of Pipeline Products by Development Stage
- T2 Biosystems Inc Pipeline Products Summary by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc Ongoing Clinical Trials Summary
- Comprehensive Sepsis Panel - Product Status
- Comprehensive Sepsis Panel - Product Description
- Monkeypox Molecular Diagnostic Test Kit - Product Status
- Monkeypox Molecular Diagnostic Test Kit - Product Description
- Next Generation T2Dx Instrument - Product Status
- Next Generation T2Dx Instrument - Product Description
- T2Bacteria Panel - Pediatrics - Product Status
- T2Bacteria Panel - Pediatrics - Product Description
- T2Candida Panel - Product Status
- T2Candida Panel - Product Description
- T2Candida Panel - Invasive Candidiasis in Critical Care
- T2Carba Resistance - Product Status
- T2Carba Resistance - Product Description
- T2Cauris Panel - Product Status
- T2Cauris Panel - Product Description
- T2Dx - Cancer - Product Status
- T2Dx - Cancer - Product Description
- T2Dx - Cardiac - Product Status
- T2Dx - Cardiac - Product Description
- T2Dx Instrument - Product Status
- T2Dx Instrument - Product Description
- T2Endotoxin - Product Status
- T2Endotoxin - Product Description
- T2HemoStat - Product Status
- T2HemoStat - Product Description
- T2Lyme Panel - Product Status
- T2Lyme Panel - Product Description
- T2MR Assay - Platelet Function Testing - Product Status
- T2MR Assay - Platelet Function Testing - Product Description
- T2Plex - Product Status
- T2Plex - Product Description
- T2Resistance Panel - Product Status
- T2Resistance Panel - Product Description
- T2Resistance Panel - Expansion - Product Status
- T2Resistance Panel - Expansion - Product Description
- T2 Biosystems Inc, Key Employees
- T2 Biosystems Inc, Subsidiaries
- Glossary
- List of Figures
- T2 Biosystems Inc Pipeline Products by Equipment Type
- T2 Biosystems Inc Pipeline Products by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.